These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 16446156)

  • 21. Mechanisms of androgen receptor signalling via steroid receptor coactivator-1 in prostate.
    Powell SM; Christiaens V; Voulgaraki D; Waxman J; Claessens F; Bevan CL
    Endocr Relat Cancer; 2004 Mar; 11(1):117-30. PubMed ID: 15027889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural and functional analysis of amino-terminal enhancer of split in androgen-receptor-driven transcription.
    Zhang Y; Gao S; Wang Z
    Biochem J; 2010 Apr; 427(3):499-511. PubMed ID: 20163360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting Androgen Receptor Activation Function-1 with EPI to Overcome Resistance Mechanisms in Castration-Resistant Prostate Cancer.
    Yang YC; Banuelos CA; Mawji NR; Wang J; Kato M; Haile S; McEwan IJ; Plymate S; Sadar MD
    Clin Cancer Res; 2016 Sep; 22(17):4466-77. PubMed ID: 27140928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of the functional domains of ANT-1, a novel coactivator of the androgen receptor.
    Fan S; Goto K; Chen G; Morinaga H; Nomura M; Okabe T; Nawata H; Yanase T
    Biochem Biophys Res Commun; 2006 Mar; 341(1):192-201. PubMed ID: 16414017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The presence of both the amino- and carboxyl-terminal domains in the AR is essential for the completion of a transcriptionally active form with coactivators and intranuclear compartmentalization common to the steroid hormone receptors: a three-dimensional imaging study.
    Saitoh M; Takayanagi R; Goto K; Fukamizu A; Tomura A; Yanase T; Nawata H
    Mol Endocrinol; 2002 Apr; 16(4):694-706. PubMed ID: 11923466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of two distinct functional isoforms of dosage-sensitive sex reversal-adrenal hypoplasia congenita-critical region on the X chromosome gene 1 (DAX-1) by alternative splicing.
    Hossain A; Li C; Saunders GF
    Mol Endocrinol; 2004 Jun; 18(6):1428-37. PubMed ID: 15044589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Domain interactions between coregulator ARA(70) and the androgen receptor (AR).
    Zhou ZX; He B; Hall SH; Wilson EM; French FS
    Mol Endocrinol; 2002 Feb; 16(2):287-300. PubMed ID: 11818501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BS69, a corepressor interacting with ZHX1, is a bifunctional transcription factor.
    Ogata-Kawata H; Yamada K; Uesaka-Yoshino M; Kagawa N; Miyamoto K
    Front Biosci; 2007 Jan; 12():1911-26. PubMed ID: 17127430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Androgen receptor and SMRT].
    Liao GQ; Tang HH; Lü XS
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Apr; 29(2):157-62. PubMed ID: 16145900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Negative modulation of androgen receptor transcriptional activity by Daxx.
    Lin DY; Fang HI; Ma AH; Huang YS; Pu YS; Jenster G; Kung HJ; Shih HM
    Mol Cell Biol; 2004 Dec; 24(24):10529-41. PubMed ID: 15572661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RWDD1 interacts with the ligand binding domain of the androgen receptor and acts as a coactivator of androgen-dependent transactivation.
    Grötsch H; Kunert M; Mooslehner KA; Gao Z; Struve D; Hughes IA; Hiort O; Werner R
    Mol Cell Endocrinol; 2012 Jul; 358(1):53-62. PubMed ID: 22406838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel mutation F826L in the human androgen receptor in partial androgen insensitivity syndrome; increased NH2-/COOH-terminal domain interaction and TIF2 co-activation.
    Wong HY; Hoogerbrugge JW; Pang KL; van Leeuwen M; van Royen ME; Molier M; Berrevoets CA; Dooijes D; Dubbink HJ; van de Wijngaart DJ; Wolffenbuttel KP; Trapman J; Kleijer WJ; Drop SL; Grootegoed JA; Brinkmann AO
    Mol Cell Endocrinol; 2008 Sep; 292(1-2):69-78. PubMed ID: 18656523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disrupted amino- and carboxyl-terminal interactions of the androgen receptor are linked to androgen insensitivity.
    Thompson J; Saatcioglu F; Jänne OA; Palvimo JJ
    Mol Endocrinol; 2001 Jun; 15(6):923-35. PubMed ID: 11376111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The corepressors silencing mediator of retinoid and thyroid hormone receptor and nuclear receptor corepressor are involved in agonist- and antagonist-regulated transcription by androgen receptor.
    Yoon HG; Wong J
    Mol Endocrinol; 2006 May; 20(5):1048-60. PubMed ID: 16373395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of three glutamine tracts in human androgen receptor transactivation.
    Harada N; Mitani T; Higashimura Y; Yamaji R; Okamoto K; Nakano Y; Inui H
    J Steroid Biochem Mol Biol; 2010 Jan; 118(1-2):77-84. PubMed ID: 19833203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The tumor suppressor ING1b is a novel corepressor for the androgen receptor and induces cellular senescence in prostate cancer cells.
    Esmaeili M; Jennek S; Ludwig S; Klitzsch A; Kraft F; Melle C; Baniahmad A
    J Mol Cell Biol; 2016 Jun; 8(3):207-20. PubMed ID: 26993046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The CCAAT enhancer-binding protein-alpha negatively regulates the transactivation of androgen receptor in prostate cancer cells.
    Chattopadhyay S; Gong EY; Hwang M; Park E; Lee HJ; Hong CY; Choi HS; Cheong JH; Kwon HB; Lee K
    Mol Endocrinol; 2006 May; 20(5):984-95. PubMed ID: 16455820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of androgen receptor transactivation and prostate cancer cell growth by heterogeneous nuclear ribonucleoprotein A1 via interaction with androgen receptor coregulator ARA54.
    Yang Z; Chang YJ; Miyamoto H; Yeh S; Yao JL; di Sant'Agnese PA; Tsai MY; Chang C
    Endocrinology; 2007 Mar; 148(3):1340-9. PubMed ID: 17110431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systematic and functional characterization of novel androgen receptor variants arising from alternative splicing in the ligand-binding domain.
    Uo T; Dvinge H; Sprenger CC; Bradley RK; Nelson PS; Plymate SR
    Oncogene; 2017 Mar; 36(10):1440-1450. PubMed ID: 27694897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The amino terminus of the human AR is target for corepressor action and antihormone agonism.
    Dotzlaw H; Moehren U; Mink S; Cato AC; Iñiguez Lluhí JA; Baniahmad A
    Mol Endocrinol; 2002 Apr; 16(4):661-73. PubMed ID: 11923464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.